1 Min Read
July 10 (Reuters) -
* Boston Biomedical announces orphan drug designation by FDA for investigational WT1 cancer peptide vaccine DSP-7888 in myelodysplastic syndrome Source text for Eikon:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.